Efficacy and safety of traditional and surgical treatment modalities in segmental vitiligo: A review article

Author:

Khalili Maryam1,Amiri Rezvan2,Mohammadi Saman2,Iranmanesh Behzad2,Aflatoonian Mahin2ORCID

Affiliation:

1. Department of Dermatology Kerman University of Medical Sciences Kerman Iran

2. Department of Dermatology Afzalipour Faculty of Medicine Afzalipour Hospital Kerman University of Medical Sciences Kerman Iran

Abstract

AbstractBackgroundSegmental vitiligo (SV) is a distinctive variant of vitiligo that is usually resistant to traditional treatments. Therefore, surgical therapies are mainstay of treatment in this type of vitiligo. To date, there is no review article or systematic review that evaluates specifically efficacy of treatment modalities on SV.AimTo evaluate current evidence regarding efficacy and safety of traditional and surgical treatment modalities in SV.MethodsWe conducted a search in PubMed, Embase, Web of science, and Google Scholar for key words of "vitiligo" AND "segmental" AND "treatment" OR "therapy" OR "surgical treatments" OR "medical treatments" OR "laser" OR "phototherapy". Inclusion criteria were English literature that investigated efficacy of different treatments on three or more cases on SV from January 2000 until July 2021.ResultsA total of thirty‐four articles were selected for detailed assessment. Different treatment modalities include medical treatment [systemic corticosteroid (SCS), topical CS (TCS), and topical calcineurin inhibitors (TCI)], phototherapy [narrow band‐ultraviolet B (NB‐UVB), psoralen and UVA (PUVA) and psoralen+solar exposure (PUVASOL)], laser/lights [helium‐neon and Excimer laser/light (EL)] and surgical treatments [punch graft (PG), follicular graft, suction blister epidermal grafting (SBEG), spilt‐thickness skin graft (STSG), and cultured/non‐cultured‐melanocytes‐keratinocytes transplantation (MKTP)].ConclusionThere were few randomized controlled trials (RCT) evaluating the efficacy of treatments in SV. Therefore, future high quality studies are required for better assessment of various treatment modalities in SV. Results of current evidence indicate resistance of SV to traditional therapies unless in patients with short duration of vitiligo. Therefore, surgical interventions are the first‐line of treatment in refractory cases, long‐standing disease, or presence of leukotrichia in depigmented patches.

Publisher

Wiley

Reference38 articles.

1. Evaluation of quality of life in parents of the patients with vitiligo by Persian version of the family dermatology life quality index (FDLQI) in Kerman;Saeedeh F;J Pak Assoc Dermatol,2019

2. Efficacy of combination therapy of pimecrolimus 1% cream and mometasone cream with either agent alone in the treatment of childhood vitiligo;Farajzadeh S;J Pak Assoc Dermatol,2019

3. Epidemiological aspects and disease association of childhood vitiligo;Farajzadeh S;J Pak Assoc Dermatol,2016

4. The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration

5. A Pilot Study of 1% Pimecrolimus Cream for the Treatment of Childhood Segmental Vitiligo

Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3